GAMMA Investing LLC Has $141,000 Position in Teleflex Incorporated (NYSE:TFX)

GAMMA Investing LLC grew its position in shares of Teleflex Incorporated (NYSE:TFX) by 364.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 795 shares of the medical technology company’s stock after purchasing an additional 624 shares during the quarter. GAMMA Investing LLC’s holdings in Teleflex were worth $141,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in TFX. Janus Henderson Group PLC lifted its stake in shares of Teleflex by 2.8% in the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after acquiring an additional 147,147 shares during the period. State Street Corp raised its holdings in Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after purchasing an additional 21,291 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Teleflex by 0.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock worth $278,676,000 after purchasing an additional 5,746 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in shares of Teleflex by 0.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock valued at $105,749,000 after purchasing an additional 1,884 shares during the last quarter. Finally, Point72 Asset Management L.P. increased its position in shares of Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after buying an additional 96,958 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Down 1.1 %

Teleflex stock opened at $177.87 on Friday. The firm has a 50 day simple moving average of $187.06 and a 200 day simple moving average of $216.52. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1-year low of $171.69 and a 1-year high of $256.85. The firm has a market capitalization of $8.26 billion, a price-to-earnings ratio of 35.36, a P/E/G ratio of 1.84 and a beta of 1.16.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. The company had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. During the same period in the previous year, the company posted $3.64 EPS. The firm’s revenue for the quarter was up 2.4% compared to the same quarter last year. On average, analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend was Friday, November 15th. Teleflex’s payout ratio is 27.04%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on TFX shares. Truist Financial decreased their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Royal Bank of Canada dropped their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, Mizuho dropped their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Three analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $252.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.